Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, today announced $15 million in financing to advance its technology enabling early detection of sepsis in the emergency department. Funds to be Used to Advance Diagnostic Designed to Measure Host Immune Response in Sepsis in Under 10 Minutes The … [Read more...] about Cytovale Announces $15 Million in Financing for Technology Enabling Early Sepsis Detection in the Emergency Department Funds to be Used to Advance Diagnostic Designed to Measure Host Immune Response in